Literature DB >> 20686234

Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin.

Wen-Jun Yao1, Kao-Xiang Sun, Yi Liu, Na Liang, Hong-Jie Mu, Chen Yao, Rong-Cai Liang, Ai-Ping Wang.   

Abstract

The aim of this study was to investigate the effect of Poly(amidoamine) (PAMAM) dendrimers on corneal permeation of puerarin (PUE). Permeation studies were performed using excised cornea of rabbits by a Valia-Chien diffusion apparatus. Drug-treatment studies were carried out by measuring the penetration of puerarin on cornea in PAMAM-PUE physical mixture or PAMAM-PUE complex, and cornea-treatment studies were carried out by measuring the penetration of puerarin on PAMAM dendrimer pretreated cornea in puerarin solution. The results showed that the permeability coefficient of puerarin in PAMAM-PUE physical mixture was enhanced by 2.48 (G3), 1.99 (G4) and 1.36 (G5) times on average, respectively compared to control. However, no significant permeability enhancement of puerarin in PAMAM-PUE complex was found compared to control. This may attribute to free drug concentration was lower in PAMAM-PUE complex which served as a depot and exhibited slow-released behavior of drug. Cornea-treatment studies showed that the lag time of puerarin was decreased, while the cumulative amount within 2.5 h (Q(2.5)) and the permeability coefficient of puerarin increased compared to control. The permeability coefficient of puerarin was linear correlated to the molecular weight of PAMAM dendrimer (r(2)=0.99). This indicates that higher generation of PAMAM dendrimer more easily interact with cornea or loosen the epithelium cell junctions than lower generation to increase the flux of puerarin. Overall, the study showed that PAMAM dendrimer increased the corneal permeation of puerarin mainly by altering the corneal barrier.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686234     DOI: 10.1248/bpb.33.1371

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Dendrimers for Ocular Drug Delivery.

Authors:  Michael G Lancina; Hu Yang
Journal:  Can J Chem       Date:  2017-05-11       Impact factor: 1.118

Review 3.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

4.  Comparative Pharmacokinetic Profiles of Puerarin in Rat Plasma by UHPLC-MS/MS after Oral Administration of Pueraria lobata Extract and Pure Puerarin.

Authors:  Guozhe Zhang; Jianwei Ji; Mingzhong Sun; Yuqiao Ji; Hongjian Ji
Journal:  J Anal Methods Chem       Date:  2020-04-14       Impact factor: 2.193

Review 5.  Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery.

Authors:  Dawin Khiev; Zeinab A Mohamed; Riddhi Vichare; Ryan Paulson; Sofia Bhatia; Subhra Mohapatra; Glenn P Lobo; Mallika Valapala; Nagaraj Kerur; Christopher L Passaglia; Shyam S Mohapatra; Manas R Biswal
Journal:  Nanomaterials (Basel)       Date:  2021-01-12       Impact factor: 5.076

Review 6.  Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.

Authors:  Liang Zhang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 7.  Nanotechnology for Age-Related Macular Degeneration.

Authors:  Bo Yang; Ge Li; Jiaxin Liu; Xiangyu Li; Shixin Zhang; Fengying Sun; Wenhua Liu
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.